Gillian C. Ivers-Read
No más puestos en curso
Historial de carrera de Gillian C. Ivers-Read
Antiguos cargos conocidos de Gillian C. Ivers-Read.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIO-PATH HOLDINGS, INC. | Director/Miembro de la Junta | 01/01/2008 | 28/10/2014 |
| Independent Dir/Board Member | 01/01/2008 | 28/10/2014 | |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Corporate Officer/Principal | 01/04/2002 | 15/04/2011 |
| Hoechst Marion Roussel, Inc. | Consejero General | 01/01/1996 | 01/01/2001 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Consejero General | - | 01/01/2001 |
| Argus Pharmaceuticals, Inc. | Consejero General | 01/01/1994 | 01/01/1996 |
| Marion Merrell Dow, Inc. | Consejero General | 01/01/1984 | 01/01/1994 |
| CLOVIS ONCOLOGY, INC. | Fundador | 20/04/2009 | - |
| Consejero General | 20/04/2009 | - |
Formación de Gillian C. Ivers-Read.
| University College London | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Reino Unido | 2 |
Operativa
| General Counsel | 5 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIO-PATH HOLDINGS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Argus Pharmaceuticals, Inc. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO. | Health Technology |
